{"id":126528,"date":"2026-01-05T15:43:07","date_gmt":"2026-01-05T15:43:07","guid":{"rendered":"https:\/\/www.europesays.com\/se\/126528\/"},"modified":"2026-01-05T15:43:07","modified_gmt":"2026-01-05T15:43:07","slug":"massiv-kampanj-ska-ge-novo-nordisk-forsprang-i-usa","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/se\/126528\/","title":{"rendered":"Massiv kampanj ska ge Novo Nordisk f\u00f6rspr\u00e5ng i USA"},"content":{"rendered":"<p>Den danska l\u00e4kemedelsj\u00e4tten Novo Nordisk vill skaffa sig ett f\u00f6rspr\u00e5ng mot konkurrenterna med en aggressiv f\u00f6rs\u00e4ljningskampanj i USA, skriver Berlingske. <\/p>\n<p>Amerikaner erbjuds fr\u00e5n och med i\u202fdag viktminskningsl\u00e4kemedlet Wegovy i tablettform till en inledande kostnad av 149 dollar i m\u00e5naden, i tre och en halv m\u00e5nad. <\/p>\n<p>Kampanjen drar i\u202fg\u00e5ng inf\u00f6r att konkurrenten Eli Lilly i mars v\u00e4ntas f\u00e5 bolagets viktminskningspiller godk\u00e4nt av myndigheterna. Novo Nordisk fick det positiva beskedet i december. <\/p>\n<p>Omni \u00e4r politiskt obundna och oberoende. Vi str\u00e4var efter att ge fler perspektiv p\u00e5 nyheterna. Har du fr\u00e5gor eller synpunkter kring v\u00e5r rapportering? <a href=\"https:\/\/omni.se\/massiv-kampanj-ska-ge-novo-nordisk-forsprang-i-usa\/a\/mailto:redaktion@omni.se\" class=\"ArticleActions_contactLink__W2F1M\" rel=\"nofollow noopener\" target=\"_blank\">Kontakta redaktionen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Den danska l\u00e4kemedelsj\u00e4tten Novo Nordisk vill skaffa sig ett f\u00f6rspr\u00e5ng mot konkurrenterna med en aggressiv f\u00f6rs\u00e4ljningskampanj i USA,&hellip;\n","protected":false},"author":2,"featured_media":126529,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[65],"tags":[72,70,71,6631,538,1206,34,31,33,32,30],"class_list":{"0":"post-126528","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-ekonomi","8":"tag-business","9":"tag-economy","10":"tag-ekonomi","11":"tag-eli-lilly","12":"tag-lakemedel-medicinteknik","13":"tag-novo-nordisk","14":"tag-se","15":"tag-svenska","16":"tag-sverige","17":"tag-sweden","18":"tag-swedish"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@se\/115843262257139711","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/126528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/comments?post=126528"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/posts\/126528\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media\/126529"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/media?parent=126528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/categories?post=126528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/se\/wp-json\/wp\/v2\/tags?post=126528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}